Fig. 7
From: FOXD3 may be a new cellular target biomarker as a hypermethylation gene in human ovarian cancer
FOXD3 hypermethylation suppresses ovarian cancer cycle in vitro. a–d Flow cytometry was performed to detect the cell cycle, the data showed that FOXD3 overexpression group and demethylation group was significantly longer than that of control group, *p < 0.05. e, f Expression levels of FOXD3 in SKOV3 and OV90 cells. The results showed that the expression level of SKOV3 in the over-expression FOXD3 group and the demethylated group was higher than that in the control group